NCT07907783: Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia
- State
- Under way
- Phase
- Phase 2
- People
- 200 planned
- Started
- 10 Nov 2026
- Primary completion
- Sep 2027
- Arms
- PP405 0.05% Topical Gel
- Results
- None posted
- 30 Oct 2026: Trial registered